Relationship Between Serum Indirect Bilirubin Levels and Cardiovascular Events and All-Cause Mortality in Maintenance Hemodialysis Patients

References

• Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33(suppl_3):iii28–iii34. doi:10.1093/ndt/gfy174
   PubMed Web of Science ®Google Scholar
• de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302(16):1782–1789. doi:10.1001/jama.2009.1488
   PubMed Web of Science ®Google Scholar
• Stec DE, Storm MV, Pruett BE, Gousset MU. Antihypertensive actions of moderate hyperbilirubinemia: role of superoxide inhibition. Am J Hypertens. 2013;26(7):918–923. doi:10.1093/ajh/hpt038
   PubMed Web of Science ®Google Scholar
• Maruhashi T, Kihara Y, Higashi Y. Bilirubin and endothelial function. J Theroscler Thromb. 2019;26(8):688–696. doi:10.5551/jat.RV17035
   PubMed Web of Science ®Google Scholar
• Tran DT, Jeong YY, Kim JM, Bae HB, Son SK, Kwak SH. The anti-inflammatory role of bilirubin on “two-hit” sepsis animal model. Int J Mol Sci. 2020;21(22):8650. doi:10.3390/ijms21228650
   PubMed Web of Science ®Google Scholar
• Bulmer AC, Verkade HJ, Wagner KH. Bilirubin and beyond: a review of lipid status in Gilbert’s syndrome and its relevance to cardiovascular disease protection. Prog Lipid Res. 2013;52(2):193–205. doi:10.1016/j.plipres.2012.11.001
   PubMed Web of Science ®Google Scholar
• Li J, Liu D, Liu Z. Serum total bilirubin and progression of chronic kidney disease and mortality: a systematic review and meta-analysis. Front Med. 2021;25(7):549. doi:10.3389/fmed.2020.00549
   Web of Science ®Google Scholar
• Tanaka S, Ninomiya T, Masutani K, et al. Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy. Clin Exp Nephrol. 2015;19(6):1062–1070. doi:10.1007/s10157-015-1096-0
   PubMed Web of Science ®Google Scholar
• Tsujikawa H, Tanaka S, Hara M, et al. Association of lower serum bilirubin with loss of residual kidney function in peritoneal dialysis patients. Ther Apher Dial. 2020;24(2):202–207. doi:10.1111/1744-9987.12865
   PubMed Web of Science ®Google Scholar
• Salvatore T, Galiero R, Caturano A, et al. Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options. Biomedicines. 2022;10(9):2274. doi:10.3390/biomedicines10092274
   PubMed Web of Science ®Google Scholar
• Jain V, Ghosh RK, Bandyopadhyay D, et al. Serum bilirubin and coronary artery disease: intricate relationship, pathophysiology, and recent evidence. Curr Probl Cardiol. 2021;46(3):100431. doi:10.1016/j.cpcardiol.2019.06.003
   PubMedGoogle Scholar
• Li C, Wu W, Song Y, Xu S, Wu X. The nonlinear relationship between total bilirubin and coronary heart disease: a dose-response meta-analysis. Front Cardiovasc Med. 2022;8:761520. doi:10.3389/fcvm.2021.761520
   PubMed Web of Science ®Google Scholar
• Lan Y, Liu H, Liu J, Zhao H, Wang H. The relationship between serum bilirubin levels and peripheral arterial disease and gender difference in patients with hypertension: BEST study. Angiology. 2020;71(4):340–348. doi:10.1177/0003319719900734
   PubMed Web of Science ®Google Scholar
• Choi Y, Lee SJ, Spiller W, et al. Causal associations between serum bilirubin levels and decreased stroke risk: a two-sample Mendelian randomization study. Arterioscler Thromb Vasc Biol. 2020;40(2):437–445. doi:10.1161/ATVBAHA.119.313055
   PubMed Web of Science ®Google Scholar
• Vitek L, Hubacek JA, Pajak A, et al. Association between plasma bilirubin and mortality. Ann Hepatol. 2019;18(2):379–385. doi:10.1016/j.aohep.2019.02.001
   PubMed Web of Science ®Google Scholar
• Chen SC, Lin CP, Hsu HC, et al. Serum bilirubin improves the risk predictions of cardiovascular and total death in diabetic patients. Clin Chim Acta. 2019;488:1–6. doi:10.1016/j.cca.2018.10.028
   PubMed Web of Science ®Google Scholar
• Zhan X, Yang M, Chen Y, et al. Relationship between serum bilirubin levels and mortality in patients on peritoneal dialysis. Ren Fail. 2019;41(1):532–539. doi:10.1080/0886022X.2019.1628062
   PubMed Web of Science ®Google Scholar
• Tian ML, Song WL, Li Q, et al. Association of low serum indirect bilirubin level with all-cause mortality in maintenance hemodialysis patients. Zhonghua Yi Xue Za Zhi. 2019;99(28):2203–2207. doi:10.3760/cma.j.issn.0376-2491.2019.28.010
   PubMedGoogle Scholar
• Ho Y, Chen TW, Huang TP, Chen YH, Tarng DC. Bilirubin links HO-1 and UGT1A1*28 gene polymorphisms to predict cardiovascular outcome in patients receiving maintenance hemodialysis. Antioxidants. 2021;10(9):1403. doi:10.3390/antiox10091403
   Web of Science ®Google Scholar
• Yao HM, Shen DL, Zhao XY, et al. Prognostic value of total bilirubin in patients with angina pectoris undergoing percutaneous coronary intervention. Int J Clin Exp Med. 2015;8(9):15930–15939.
   PubMed Web of Science ®Google Scholar
• Zulus B, Grünbacher G, Kleber ME, März W, Renner W. The UGT1A1*28 gene variant predicts long-term mortality in patients undergoing coronary angiography. Clin Chem Lab Med. 2018;56(4):560–564. doi:10.1515/cclm-2017-0692
   PubMed Web of Science ®Google Scholar
• Su H, Kao C, Lin Y, et al. Relationship between serum total bilirubin levels and mortality in uremia patients undergoing long-term hemodialysis. Atherosclerosis. 2017;265:155–161. doi:10.1016/j.atherosclerosis.2017.09.001
   PubMed Web of Science ®Google Scholar
• Chung SR, Yang TH, Shin HC, et al. Initial total bilirubin and clinical outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stents. Circ J. 2016;80(6):1437–1444. doi:10.1253/circj.CJ-15-1397
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Heimbürger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899–1911. doi:10.1046/j.1523-1755.1999.00422.x
   PubMed Web of Science ®Google Scholar
• Bulmer AC, Bakrania B, Du Toit EF, et al. Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea. Am J Physiol Heart Circ Physiol. 2018;315(3):H429–H447. doi:10.1152/ajpheart.00417.2017
   PubMed Web of Science ®Google Scholar
• Maruhashi T, Soga J, Fujimura N, et al. Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation. 2012;126(5):598–603. doi:10.1161/CIRCULATIONAHA.112
   PubMed Web of Science ®Google Scholar
• Ndisang JF, Jadhav A. Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months. J Card Fail. 2009;15(7):616–628. doi:10.1016/j.cardfail.2009.02.003
   PubMed Web of Science ®Google Scholar
• Ben-Amotz R, Bonagura J, Velayutham M, Hamlin R, Burns P, Adin C. Intraperitoneal bilirubin administration decreases infarct area in a rat coronary ischemia/reperfusion model. Front Physiol. 2014;5:53. doi:10.3389/fphys.2014.00053
   PubMed Web of Science ®Google Scholar
• Querido S, Quadros Branco P, Silva Sousa H, et al. Hypervolemia, hypoalbuminemia and mitral calcification as markers of cardiovascular risk in peritoneal dialysis patients. Rev Port Cardiol. 2017;36(9):599–604. doi:10.1016/j.repc.2016.12.014
   PubMedGoogle Scholar